We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TKC icon
6451
Turkcell
TKC
$4.78B
$27K ﹤0.01%
4,086
-82,477
-95% -$624K
UXIN
6452
Uxin Ltd
UXIN
$229M
$27K ﹤0.01%
+30
New +$28.5K
RPT
6453
Rithm Property Trust
RPT
$93.7M
$27K ﹤0.01%
354
+303
+594% +$23.3K
MAXR
6454
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$27K ﹤0.01%
532
-33
-6% -$1.56K
CCXI
6455
DELISTED
ChemoCentryx, Inc.
CCXI
$27K ﹤0.01%
2,058
+808
+65% +$9.66K
TCTL
6456
DELISTED
Premise Capital Diversified Tactical ETF
TCTL
$27K ﹤0.01%
916
-37
-4% -$1.11K
AXU
6457
DELISTED
Alexco Resource Corp
AXU
$27K ﹤0.01%
20,489
+18,510
+935% +$26.2K
GFED
6458
DELISTED
Guaranty Federal Bancshares In
GFED
$27K ﹤0.01%
1,108
-384
-26% -$9.04K
SWP
6459
DELISTED
Stanley Black & Decker, Inc. Corporate Units
SWP
$27K ﹤0.01%
255
QHC
6460
DELISTED
Quorum Health Corporation
QHC
$27K ﹤0.01%
5,310
-52,916
-91% -$339K
MLNT
6461
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$27K ﹤0.01%
839
+488
+139% +$17.6K
DNBF
6462
DELISTED
DNB Financial Corp
DNBF
$27K ﹤0.01%
778
+4
+0.5% +$140
DEMG
6463
DELISTED
Xtrackers FTSE Emerging Comprehensive Factor ETF
DEMG
$27K ﹤0.01%
1,056
+1,023
+3,100% +$28.3K
OMAD.U
6464
DELISTED
One Madison Corporation
OMAD.U
$27K ﹤0.01%
2,674
-1,400
-34% -$14.1K
UCBA
6465
DELISTED
United Community Bancorp
UCBA
$27K ﹤0.01%
1,000
-219
-18% -$5.8K
DBV
6466
DELISTED
Invesco DB G10 Currency Harvest Fund
DBV
$27K ﹤0.01%
1,085
-41
-4% -$991
IMDZ
6467
DELISTED
Immune Design Corp.
IMDZ
$27K ﹤0.01%
+5,863
New +$23.4K
ISRL
6468
DELISTED
Isramco Inc
ISRL
$27K ﹤0.01%
+221
New +$24.2K
AMPY icon
6469
Amplify Energy
AMPY
$170M
$26K ﹤0.01%
+1,877
New +$25.4K
APPS icon
6470
Digital Turbine
APPS
$1.64B
$26K ﹤0.01%
17,498
+5,502
+46% +$9.43K
AVXL icon
6471
PUT
Anavex Life Sciences
AVXL
$301M
$26K ﹤0.01%
+9,900
New +$27.7K
BELFB
6472
Bel Fuse Inc Class B
BELFB
$4.29B
$26K ﹤0.01%
1,235
+307
+33% +$6.2K
CENX icon
6473
Century Aluminum
CENX
$4.79B
$26K ﹤0.01%
1,650
+950
+136% +$16.1K
FENG
6474
Phoenix New Media
FENG
$17.8M
$26K ﹤0.01%
993
-468
-32% -$13K
IMOS
6475
ChipMOS TECHNOLOGIES
IMOS
$1.83B
$26K ﹤0.01%
1,431
-621
-30% -$10.8K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.